A new Boxed Warning will be required in the prescribing information for several insomnia medications following reports of serious injuries and deaths associated with complex sleep behaviors where patients engaged in activities while not fully awake.
The number of annual diagnoses in this UK center increased over the study period, but there was no evidence that the time from symptom onset to diagnosis was decreasing.
Rapid eye movement sleep behavior disorder features may be a clinical marker for faster cognitive decline in Parkinson disease.
The FDA has approved Sunosi to improve wakefulness in adults with excessive daytime sleepiness associated with narcolepsy or OSA.
Predictors of neurodegeneration from idiopathic REM sleep behavior disorder have been identified.
Older adults who are witnessed to have sleep apnea have increased accumulations of tau in the entorhinal cortex.
An alternative-medicine treatment modality such as acupuncture may provide clinically significant relief for sleep disturbance affecting veterans.
Some sleep-related movement disorders are well known, like restless legs syndrome, but less common sleep-related movement disorders are often overlooked.
Harmony Biosciences announced that the FDA has accepted for Priority Review the New Drug Application for pitolisant for the treatment of excessive daytime sleepiness and/or cataplexy in adults with narcolepsy.
More children with autism spectrum disorder have sleep problems compared with other children.
